Literature DB >> 25935758

Administration of TLR7 agonist, resiquimod, in different types of chicken induces a mixed Th1 and Th2 response in the peripheral blood mononuclear cells.

Arunsaravanakumar Annamalai1, Saravanan Ramakrishnan2, Swati Sachan1, Bal Krishan Sharma1, B S Anand Kumar1, Vimal Kumar1, Surendra Kumar Badasara1, Ajay Kumar3, B C Saravanan4, Narayanan Krishnaswamy5.   

Abstract

This study evaluated the variation in immune response in peripheral blood mononuclear cells (PBMCs) of broiler, White Leghorn (WL) and Kadaknath breeds of chicken following administration of TLR7 agonist, resiquimod (R-848). Expression of different immune related genes viz., interferon-β (IFN-β), IFN-γ, IL-1β, IL-4, TLR7 and iNOS was assessed by quantitative real time PCR over a period of 24 h. The results indicated that there was a significant up-regulation in the relative expression of immune response genes post R-848 administration (P < 0.01). In conclusion, the transcriptional expression of IFN-β, IFN-γ, IL-1β, IL-4, iNOS and TLR7 genes in the PBMCs was significantly up-regulated over 24 h in broiler, WL and Kadaknath breeds of birds after the administration of R-848. Overall, R-848 induced a mixed Th1 and Th2 response in PBMCs of chicken origin ex vivo.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chicken; Immune response genes; PBMCs; Resiquimod; Toll-like receptors

Mesh:

Substances:

Year:  2015        PMID: 25935758     DOI: 10.1016/j.rvsc.2015.04.007

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck.

Authors:  Aiguo Zhang; Deyin Li; Chao Song; Huiyuan Jing; Hongfei Li; Junxian Mi; Guizhi Zhang; Shuangxing Jin; Xiaoli Ren; Heping Huangfu; Dongmei Shi; Ruiai Chen
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

2.  In Ovo Delivered Toll-Like Receptor 7 Ligand, Resiquimod Enhances Host Responses against Infectious Bronchitis Corona Virus (IBV) Infection.

Authors:  Upasama De Silva Senapathi; Mohamed Aboelkhair; Kekungu Puro; Mariam Ali; Aruna Amarasinghe; M Sarjoon Abdul-Cader; Guido Van Marle; Markus Czub; Mohamed Faizal Abdul-Careem
Journal:  Vaccines (Basel)       Date:  2020-04-15

3.  Screening of immune-related differentially expressed genes from primary lymphatic organs of broilers fed with probiotic bacillus cereus PAS38 based on suppression subtractive hybridization.

Authors:  Jiajun Li; Wanqiang Li; Zhenhua Wang; Abdul Khalique; Junrui Wang; Miao Yang; Xueqin Ni; Dong Zeng; Dongmei Zhang; Yan Zeng; Qihui Luo; Bo Jing; Kangcheng Pan
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

4.  Antiviral response elicited against avian influenza virus infection following activation of toll-like receptor (TLR)7 signaling pathway is attributable to interleukin (IL)-1β production.

Authors:  Mohamed Sarjoon Abdul-Cader; Upasama De Silva Senapathi; Eva Nagy; Shayan Sharif; Mohamed Faizal Abdul-Careem
Journal:  BMC Res Notes       Date:  2018-12-04

5.  Single stranded (ss)RNA-mediated antiviral response against infectious laryngotracheitis virus infection.

Authors:  Mohamed Sarjoon Abdul-Cader; Upasama De Silva Senapathi; Hanaa Ahmed-Hassan; Shayan Sharif; Mohamed Faizal Abdul-Careem
Journal:  BMC Microbiol       Date:  2019-02-08       Impact factor: 3.605

Review 6.  Newcastle disease vaccines-A solved problem or a continuous challenge?

Authors:  Kiril M Dimitrov; Claudio L Afonso; Qingzhong Yu; Patti J Miller
Journal:  Vet Microbiol       Date:  2016-12-16       Impact factor: 3.293

7.  Roles of TLR7 in Schistosoma japonicum Infection-Induced Hepatic Pathological Changes in C57BL/6 Mice.

Authors:  Yuanfa Feng; Hongyan Xie; Feihu Shi; Dianhui Chen; Anqi Xie; Jiajie Li; Chao Fang; Haixia Wei; He Huang; Xingfei Pan; Xiaoping Tang; Jun Huang
Journal:  Front Cell Infect Microbiol       Date:  2021-10-08       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.